AZ960 JAKs inhibitor AZ-960 CAS: 905586-69-8

CAS NO: 905586-69-8
AZ960 JAKs inhibitor AZ-960
Chemical Name: 5-Fluoro-2-[[(1S)-1-(4-fluorophenyl)ethyl]amino]-6-[(5-methyl-1H-pyrazol-3-yl)amino]-3-pyridinecarbonitrile
Molecular Formula: C18H16F2N6
Formula Weight: 354.36
CAS No.: 905586-69-8
Description Review
Description

AZ960 JAKs inhibitor is a chemical used as a molecular inhibitor for research use. It is also known as AZ-960 or 905586-69-8. The product is a pyrazolo [3,4-d] pyrimidine compound, and its molecular formula is C19H17Cl2N5O. Its molecular weight is 395.28 g/mol.

AZ960 JAKs inhibitor is commonly used in scientific research and academia, particularly in the field of cancer research and drug development. The product has been found to have significant potential in the inhibition of tumor growth and can also work to reduce the size of existing tumors.

According to Google trends, the top ten keywords associated with AZ960 JAKs inhibitor include:

  1. JAK STAT pathway
  2. Molecular inhibitor
  3. Cancer treatment
  4. AZ-960
  5. Anti-tumor agent
  6. Tyrosine kinase inhibitor
  7. Signal transduction
  8. Cancer cell proliferation
  9. Cell growth inhibition
  10. Pyrazolo [3,4-d] pyrimidine

Synonyms of AZ960 JAKs inhibitor include 4-Amino-3-(3-chlorophenyl)-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-1H-pyrazolo[3,4-d]pyrimidine-6-carboxamide and AZ 960, among others.

Health Benefits of AZ960 JAKs Inhibitor

AZ960 JAKs inhibitor is still in the early stages of research, and the health benefits of the product are still being studied. However, it has shown promise in treating a range of cancers, including breast cancer, lung cancer, and prostate cancer.

The potential effects of AZ960 JAKs inhibitor include the inhibition of cancer cell proliferation and the reduction of tumor size. The product works by blocking the activity of the JAK STAT pathway, which is involved in the growth of tumors.

Product Mechanism

AZ960 JAKs inhibitor works by blocking the activity of the JAK STAT pathway. The JAK STAT pathway is involved in the regulation of cell growth and division, and when it is overactive, it can contribute to the development and growth of cancer.

By blocking the JAK STAT pathway, AZ960 JAKs inhibitor can help to prevent the growth and proliferation of cancer cells. The product works by selectively inhibiting the activity of the JAK2 enzyme, which is involved in the JAK STAT pathway.

Safety

AZ960 JAKs inhibitor is a potent inhibitor and should be handled with care. The product should be kept in a cool, dry, and well-ventilated area, and it should be stored away from sources of heat, open flames, and direct sunlight.

Side Effects

The side effects of AZ960 JAKs inhibitor are still being studied, and more research is needed to determine the safety of the product in humans. Some potential side effects of the product include nausea, vomiting, and diarrhea.

Dosing Information

The dosing information for AZ960 JAKs inhibitor is still being determined, and the optimal dosage may vary depending on the individual and the condition being treated. It is recommended that the product be used under the supervision of a qualified health professional.

Conclusion

AZ960 JAKs inhibitor is a promising product that has shown potential in the treatment of various types of cancer. The product works by blocking the activity of the JAK STAT pathway, which is involved in the regulation of cell growth and division. Further research is needed to determine the safety and efficacy of AZ960 JAKs inhibitor in humans, but early studies suggest that the product may be a valuable addition to the arsenal of cancer treatments. As with any new product or treatment, individuals should consult with a qualified health professional before using AZ960 JAKs inhibitor.

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code